Rare Diseases And Beyond: FDA Seeks Input On Establishing Clinical Trial Networks
Executive Summary
US FDA is looking for advice on how to design a clinical trial network to complete the third component of its Rare Disease Cures Accelerator Program, but it also wants advice on clinical trial networks more broadly. The rare disease network will need to be global given the more limited patient populations, the agency said.
You may also be interested in...
Clinical Outcome Assessments To Be Developed Under US FDA Grants
The projects could help streamline rare disease drug development, along with the Rare Disease Cures Accelerator.
Strike Two: US FDA Vaccine Advisors Again Shoot Down Broad COVID-19 Vaccine Boosting
Surprising move to have VRBPAC debate offering mRNA boosters to everyone 18 and up, less than one month after the panel shot that down for Pfizer’s vaccine, thus stalling the White House’s plan for a broad booster rollout, was driven internally by the FDA, a senior health official said.